Also serving the communities of De Luz, Rainbow, Camp Pendleton, Pala and Pauma
Sorted by date Results 1 - 23 of 23
MIKE STOBBE and NICKY FORSTER Associated Press NEW YORK (AP) - While deaths from the coronavirus in the U.S. are mounting rapidly, public health experts are seeing a flicker of good news: The second surge of confirmed cases appears to be leveling off. Scientists aren't celebrating by any means, warning that the trend is driven by four big, hard-hit places - Arizona, California, Florida and Texas - and that cases are rising in close to 30 states in all, with the outbreak's...
The Associated Press Can you get the coronavirus twice? Scientists don't know for sure yet, but they believe it's unlikely. Health experts think people who had COVID-19 will have some immunity against a repeat infection. But they don't know how much protection or how long it would last. There have been reports of people testing positive for the virus weeks after they were believed to have recovered, leading some to think they may have been reinfected. More likely, experts say...
MARILYNN MARCHIONE AP Chief Medical Writer An experimental blood test was highly accurate at distinguishing people with Alzheimer's disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia. Developing such a test has been a long-sought goal, and scientists warn that the new approach still needs more validation and is not yet ready for wide use. But Tuesday's results suggest they're...
LAURAN NEERGAARD and MICHAEL HILL AP Medical Writer The world's biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government -- one of several candidates in the final stretch of the global vaccine race. There's still no guarantee that the experimental vaccine, developed by the National Institutes of Health and Moderna Inc., will really protect. The needed proof: Volunteers won't know if they're getting the real shot or a dummy version....
MARIA CHENG AP Medical Writer LONDON (AP) - Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. Such early trials are designed to evaluate safety and see what kind of immune response was provoked, but can't tell if the...
JAY REEVES Associated Press A fast-rising tide of new coronavirus cases is flooding emergency rooms in parts of the United States, with some patients moved into hallways and nurses working extra shifts to keep up with the surge. Patients struggling to breathe are being placed on ventilators in emergency wards since intensive care units are full, officials say, and the near-constant care they require is overtaxing workers who also are treating more typical ER cases like chest pains, infections, and fractures. In Texas, Dr....
LINDSEY TANNER AP Medical Writer What role children play in the coronavirus pandemic is the hot-button question of the summer as kids relish their free time while schools labor over how to resume classes. The Trump administration says the science "is very clear," but many doctors who specialize in pediatrics and infectious diseases say much of the evidence is inconclusive. "There are still a lot of unanswered questions. That is the biggest challenge," said Dr. Sonja...
LAURAN NEERGAARD AP Medical Writer The first COVID-19 vaccine tested in the U.S. revved up people's immune systems just the way scientists had hoped, researchers reported Tuesday -- as the shots are poised to begin key final testing. "No matter how you slice this, this is good news," Dr. Anthony Fauci, the U.S. government's top infectious disease expert, told The Associated Press. The experimental vaccine, developed by Fauci's colleagues at the National Institutes of Health and Moderna Inc., will start its most important...
GEOFF MULVIHILL and CAMILLE FASSETT Associated Press The personal protective gear that was in dangerously short supply during the early weeks of the coronavirus crisis in the U.S. is running low again as the virus resumes its rapid spread and the number of hospitalized patients climbs. A national nursing union is concerned that gear has to be reused. A doctors association warns that physicians' offices are closed because they cannot get masks and other supplies. And...
LAUREN WEBER, LAURA UNGAR, MICHELLE R. SMITH, HANNAH RECHT and ANNA MARIA BARRY-JESTER Associated Press and KHN The U.S. public health system has been starved for decades and lacks the resources to confront the worst health crisis in a century. Marshaled against a virus that has sickened at least 2.6 million in the U.S., killed more than 126,000 people and cost tens of millions of jobs and $3 trillion in federal rescue money, state and local government health workers on the...
DON BABWIN and PAUL J. WEBER Associated Press For many states and counties in the U.S., the dark days of the coronavirus pandemic in April unfolded on their television screens, not on their doorsteps. But now, some places that appeared to have avoided the worst are seeing surges of infections, as worries shift from major cities to rural areas. While much of the focus of concerns that the United States is entering a dangerous new phase has been on big Sunbelt states that are reporting thousands of new cases a day — like T...
MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — How accurate are the coronavirus tests used in the U.S.? Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out. When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus. That's very d...
MIKE STOBBE AP Medical Writer NEW YORK (AP) - States are rolling back lockdowns, but the coronavirus isn't done with the U.S. Cases are rising in nearly half the states, according to an Associated Press analysis, a worrying trend that could intensify as people return to work and venture out during the summer. In Arizona, hospitals have been told to prepare for the worst. Texas has more hospitalized COVID-19 patients than at any time before. And the governor of North Carolina...
MIKE STOBBE and CARLA K. JOHNSON Associated Press NEW YORK (AP) — The spark that started the U.S. coronavirus epidemic arrived during a three-week window from mid-January to early February, before the nation halted travel from China, according to the most comprehensive federal study to date of when the virus began spreading. That means anyone in the U.S. who thought they had the virus in December or early January probably had the flu, public health researchers said. Some people have claimed Americans were getting sick from t...
MARILYNN MARCHIONE AP Chief Medical Writer New research shows how dangerous the coronavirus is for current and former cancer patients. Those who developed COVID-19 were much more likely to die within a month than people without cancer who got it, two studies found. They are the largest reports on people with both diseases in the United States, the United Kingdom, Spain and Canada. In one study, half of 928 current and former cancer patients with COVID-19 were hospitalized and 13% died. That's far more than the various rates...
MARILYNN MARCHIONE AP Chief Medical Writer An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday. Study volunteers given either a low or medium dose of the vaccine by Cambridge, Massachusetts-based Moderna Inc. had antibodies similar to those seen in people who have recovered from COVID-19. In the next phase of the study, led by the U.S. National Institutes of Health,...
JASON DEAREN and MIKE STOBBE Associated Press GAINESVILLE, Fla. (AP) - Advice from the top U.S. disease control experts on how to safely reopen businesses and institutions during the coronavirus pandemic was more detailed and restrictive than the plan released by the White House last month. The guidance, which was shelved by Trump administration officials, also offered recommendations to help communities decide when to shut facilities down again during future flareups of COVID...
TOM KRISHER Associated Press U.S. regulators have approved a new type of coronavirus test that administration officials have promoted as a key to opening up the country. The Food and Drug Administration on Saturday announced emergency authorization for antigen tests developed by Quidel Corp. of San Diego. The test can rapidly detect fragments of virus proteins in samples collected from swabs swiped inside the nasal cavity, the FDA said in a statement. The antigen test is the third type of test to be authorized by the FDA. Cur...
MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — U.S. regulators Monday pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked. The Food and Drug Administration said it took the action because some sellers have made false claims about the tests and their accuracy. Companies will now have to show their tests work or risk having them pulled from the market. Under pressure to increase testing options, the FDA in March essentially allowed c...
MATTHEW PERRONE and MARILYNN MARCHIONE Associated Press WASHINGTON (AP) — U.S. regulators on Friday allowed emergency use of the first drug that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The Food and Drug Administration cleared Gilead Science's intravenous drug for hospitalized patients with "severe disease," such as those experiencing breathing problems requiring supplemental oxygen or ventilators. President Donald Trump a...
MARILYNN MARCHIONE AP Chief Medical Writer An experimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, U.S. government and company officials announced Wednesday. Gilead Sciences's remdesivir is the first treatment to pass such a strict test against the virus, which has killed more than 218,000 people since it emerged late last year in China. Having a treatment could have...
MARILYNN MARCHIONE AP Chief Medical Writer For the first time, a blood test has been shown to help detect many types of cancer in a study of thousands of people with no history or symptoms of the disease. The test is still experimental. Even its fans say it needs to be improved and that Tuesday's results are not ideal. Yet they show what benefits and drawbacks might come from using these gene-based tests, called liquid biopsies, in routine care -- in this case, with PET scans...
JUAN A. LOZANO Associated Press HOUSTON (AP) - Secrecy surrounding executions could hinder efforts by a group of medical professionals who are asking the nation's death penalty states for medications used in lethal injections so that they can go to coronavirus patients who are on ventilators, according to a death penalty expert and a doctor who's behind the request. In a letter sent this month to corrections departments, a group of seven pharmacists, public health experts,...